Profile of Remimazolam in Anesthesiology: A Narrative Review of Clinical Research Progress

Remimazolam is a novel short-acting γ-aminobutyric acid (GABA) receptor agonist with typical characteristics of benzodiazepine sedative drugs, nonorgan-dependent metabolism, long-term infusion without accumulation, and no injection pain. It is quite different from the other current sedative drugs an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mi, Zhao, Xian, Yin, Pengfei, Bao, Xiuxia, Tang, Hongli, Kang, Xianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541296/
https://www.ncbi.nlm.nih.gov/pubmed/36213379
http://dx.doi.org/10.2147/DDDT.S375957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541296/
https://www.ncbi.nlm.nih.gov/pubmed/36213379
http://dx.doi.org/10.2147/DDDT.S375957

Ejemplares similares